Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Blood|January 13, 2018
Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndromeEric S Weiss, Charlotte Girard-Guyonvarc'h, Dirk Holzinger, et al.
Annals of the Rheumatic Diseases|March 31, 2023
Efficacy and safety of emapalumab in macrophage activation syndromeFabrizio De Benedetti, Alexei A Grom, Paul A Brogan, et al.
JCI Insight|August 10, 2018
Identification of enhanced IFN-γ signaling in polyarticular juvenile idiopathic arthritis with mass cytometryAllison A Throm, Halima Moncrieffe, Amir B Orandi, et al.
American Journal of Ophthalmology|July 21, 2022
Alternative Biologic Therapy in Children Failing Conventional TNFα Inhibitors for Refractory, Noninfectious, Chronic Anterior UveitisVirginia Miraldi Utz, Sheila T Angeles-Han, Najima Mwase, et al.
Arthritis and Rheumatism|July 1, 2009
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsetsThomas A Griffin, Michael G Barnes, Norman T Ilowite, et al.
Arthritis Research & Therapy|June 25, 2024
S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritisHermine I Brunner, Grant S Schulert, Alyssa Sproles, et al.
Arthritis Care & Research|May 13, 2017
Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic ArthritisGrant S Schulert, Francesca Minoia, John Bohnsack, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 6, 2019
Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk FactorsGrant S Schulert, Shima Yasin, Brenna Carey, et al.
Pediatric Rheumatology Online Journal|January 5, 2024
Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & EuropeAlexei A Grom, Scott W Canna, Rolla F Abu-Arja, et al.
Rheumatology (Oxford, England)|June 6, 2017
Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexateHalima Moncrieffe, Mark F Bennett, Monica Tsoras, et al.
Pageof 9